Ignite Creation Date:
2025-12-24 @ 6:26 PM
Ignite Modification Date:
2026-02-11 @ 8:24 AM
Study NCT ID:
NCT00511368
Status:
COMPLETED
Last Update Posted:
2010-01-20
First Post:
2007-08-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
Sponsor:
Myrexis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PA103001-04 Study 203
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Andrew Beelen, M.D, Sr. Director Clinical Research
Old Organization:
Myriad Pharmaceuticals